CPPE Corner: New Atrial fibrillation detection e-learning programme

CPPE Corner: New Atrial fibrillation detection e-learning programme

March 22, 2019

The Centre for Pharmacy Postgraduate Education (CPPE) is now offering an e-learning programme to help you prepare to offer an atrial fibrillation detection service in your pharmacy. We spoke to Clare Smith, CPPE Senior Pharmacist, Learning Development, to find out more.

We are pleased to introduce our brand new e-learning programme, Atrial fibrillation detection in community pharmacy: what you need to become service ready. Atrial fibrillation is the most common form of cardiac arrhythmia and results in an abnormally fast and irregular heart rate, and an increased risk of stroke.

This e-learning programme aims to help you explore current atrial fibrillation detection services in community pharmacy and support you to consider your learning and development needs for you to become service ready. As part of the programme, you will be signposted to other learning resources that will cover the clinical aspects of atrial fibrillation, such as how it is diagnosed and managed.

You will also look at how you can support patients through the service by reflecting on your current consultation skills. Finally, you will have the opportunity to watch video examples of the atrial detection service being carried out in community practice.

After completing the programme, you will be able to outline what atrial fibrillation is and how it is diagnosed and managed and you will also be supported with developing an action plan to help you deliver the detection service.

This e-learning programme is an interactive, self-study resource that is intended to take around two hours of study time and it is open to all pharmacy professionals and pre-registration trainees.

For more information about the programme and to access it, visit the CPPE website.

Posted in:

More Latest News >

Shortage Notice: Salbutamol 2mg/5ml syrup

GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol...